<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940523-0-00039</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4700 -->  <!-- PJG ITAG l=11 g=1 f=1 --> b.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> APH(3 <!-- PJG 0020 minuteslatlong --> &rsquo;)II in animal feed.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Calgene also considered the potential inactivation of neomycin that is used in animal feeds manufactured using cottonseed meal and rapeseed meal obtained from transgenic plants. The transgenic tomato was not considered because only small amounts of tomato and tomato byproducts are used in the animal feed industry. Further, neomycin is primarily used to treat calves and swine whereas tomato byproducts, to the extent that they are used in animal feed, are primarily used as ingredients in cattle diets (Ref. 27).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Calgene analyzed neomycin levels both in nontransgenic medicated cottonseed and rapeseed meals and in transgenic medicated cottonseed and rapeseed meals over a storage period of 56 days (considered a worst-case situation) and concluded that there was no significant inactivation of neomycin.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> FDA reviewed the data submitted by Calgene and concludes that there was no significant difference with respect to neomycin stability between medicated cottonseed and rapeseed meals prepared from transgenic cottonseed and rapeseed containing APH(3 <!-- PJG 0020 minuteslatlong --> &rsquo;)II, and appropriate controls (Ref. 28). Therefore, the agency concludes that transgenic strains of cottonseed and rapeseed containing APH(3 <!-- PJG 0020 minuteslatlong --> &rsquo;)II have no apparent untoward effect regarding the stability of neomycin and that the therapeutic efficacy of neomycin in animal feed will not be affected. The agency also considers this conclusion applicable to other aminoglycoside antibiotics, e.g., gentamicin, when orally administered. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> B. The Kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=5 f=3 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 -->  Gene  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The agency also evaluated issues relevant specifically to the safety of the use of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene in tomato, oilseed rape, and cotton. In particular, FDA evaluated the potential for horizontal transfer of the gene and subsequent expansion of the population of antibiotic-resistant pathogens. The agency evaluated whether efficacy of oral antibiotic treatment of humans or animals could be compromised by consumption of food containing the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene either because of the development of resistant intestinal microflora in humans and animals or because the cells lining the intestinal lumen might become transformed. In addition, the agency considered the possible transfer of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene from transgenic plants to soil microorganisms and expansion of the antibiotic-resistant bacterial population.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> 1. Potential Transfer of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 -->  Gene to Intestinal Microorganisms and Cells Lining the Intestinal Lumen  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Calgene presented theoretical and experimental evidence to demonstrate that the potential for compromise of antibiotic therapy by horizontal transfer of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene to gut microorganisms or intestinal epithelial cells is not of significant concern. Calgene considered the sources of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene, the role digestion plays in degrading DNA, and possible DNA transfer mechanisms.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> a.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Relevant source of the kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=3 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 -->  gene available for transformation.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Calgene considered potential transfer of the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene only from fresh tomatoes because processing is expected to inactivate the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene in processed tomato products and in food products derived from cotton and oilseed rape. The  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene is not expected to survive procedures used to process tomatoes because heating processes, such as those used in commercial processing, can directly degrade DNA or can damage DNA by releasing cellular DNA-degrading enzymes.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> The  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene is also not expected to survive the process of oil production from cottonseed and rapeseed. Mechanical grinding or flaking of oilseeds during the production of oils and meals from oilseeds is expected to liberate degradative enzymes normally present within the cell that would degrade the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene. In addition, oil processing also includes high temperatures and solvent extractions, both of which would be expected to inactivate the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene. Moreover, because DNA is hydrophilic, it is unlikely to fractionate into oil, which is hydrophobic, during the extraction of oil from cottonseed and rapeseed. Therefore, intact DNA, including the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene, is not expected to survive the production of oils and animal feeds from cottonseed and rapeseed.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> b.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Effect of digestion on the availability of the kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=3 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 -->  gene for possible transformation.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Calgene demonstrated that most if not all of the DNA comprising the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene ingested by humans will be degraded in the stomach and upper small intestine before it reaches the lower small intestine, cecum, and colon, and would be unavailable for potential transformation of gut microorganisms. Calgene estimated that 99.9 percent of fresh tomato DNA would be digested to fragments smaller than 1,000 base pairs. This estimate was based on in vitro studies that found that only 0.1 percent of DNA could be detected as fragments of 1,000 base pairs or longer after exposure to stomach-simulating fluids for 10 minutes and to intestinal-simulating fluids for another 10 minutes. Thus most of the DNA remaining after digestion would be smaller than the  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> kan <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> r <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  gene which is about 1,000 base pairs long.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            